Characterization of P-glycoprotein Inhibition by Major Cannabinoids from Marijuana

Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites.

Cordon‐Cardo, C., O’Brien, J. P., Casals, D., Rittmann-Grauer, L., Biedler, J. L., Melamed, M. R., & Bertino, J. R. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.2.695 · Cited by 1,750 · see citing works

Pharmacokinetics and Pharmacodynamics of Cannabinoids

Grotenhermen, F. (2003) · Clinical Pharmacokinetics · doi:10.2165/00003088-200342040-00003 · Cited by 1,514 · see citing works

Absence of the mdr1a P-Glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A.

Schinkel, A. H., Wagenaar, E., van Deemter, L., Mol, C. A. A. M., & Borst, P. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118214 · Cited by 1,108 · see citing works

MDR1 P-Glycoprotein Is a Lipid Translocase of Broad Specificity, While MDR3 P-Glycoprotein Specifically Translocates Phosphatidylcholine

van Helvoort, A., Smith, A. J., Sprong, H., Fritzsche, I., Schinkel, A. H., Borst, P., & Gerrit van, M. E. E. R. (1996) · Cell · doi:10.1016/s0092-8674(00)81370-7 · Cited by 854 · see citing works

Cannabinoids for control of chemotherapy induced nausea and vomiting: quantitative systematic review

Tramèr, M. R., Carroll, D., Campbell, F. A., Reynolds, D. J. M., Moore, R. A., & McQuay, H. J. (2001) · BMJ · doi:10.1136/bmj.323.7303.16 · Cited by 610 · see citing works

Cannabinoid receptors and their ligands

Pertwee, R. G., & Ross, R. A. (2002) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1054/plef.2001.0341 · Cited by 558 · see citing works

Prevalence of Marijuana Use Disorders in the United States: 1991-1992 and 2001-2002

Compton, W. M., Grant, B. F., Colliver, J. D., Glantz, M. D., & Stinson, F. S. (2004) · JAMA · doi:10.1001/jama.291.17.2114 · Cited by 537 · see citing works

Cannabidiol: An Overview of Some Pharmacological Aspects

Mechoulam, R., Parker, L. A., & Gallily, R. (2002) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.2002.tb05998.x · Cited by 511 · see citing works

Evidence for two nonidentical drug-interaction sites in the human P-glycoprotein

Dey, S., Ramachandra, M., Pastan, I. H., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.20.10594 · Cited by 337 · see citing works

Controlled clinical trial of cannabidiol in Huntington's disease

Consroe, P. F., Laguna, J., Allender, J. R., Snider, S. R., Stern, L. Z., Sandyk, R., Kennedy, K., & Schram, K. H. (1991) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(91)90386-g · Cited by 324 · see citing works

Development and characterisation of a rat brain capillary endothelial culture: towards an in vitro blood-brain barrier

Abbott, N. J., Hughes, C. C. W., Revest, P., & Greenwood, J. (1992) · Journal of Cell Science · doi:10.1242/jcs.103.1.23 · Cited by 318 · see citing works

Antitumor Effects of Cannabidiol, a Nonpsychoactive Cannabinoid, on Human Glioma Cell Lines

Massi, P., Vaccani, A., Ceruti, S., Colombo, A., Abbracchio, M. P., & Parolaro, D. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.061002 · Cited by 272 · see citing works

Full blockade of intestinal P-glycoprotein and extensive inhibition of blood-brain barrier P-glycoprotein by oral treatment of mice with PSC833.

Mayer, U., Wagenaar, E., Dorobek, B., et al. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119784 · Cited by 271 · see citing works

Therapeutic aspects of cannabis and cannabinoids

Robson, P. (2001) · The British Journal of Psychiatry · doi:10.1192/bjp.178.2.107 · Cited by 265 · see citing works

Basolateral localization and export activity of the human multidrug resistance-associated protein in polarized pig kidney cells.

Evers, R., Zaman, G. J. R., van Deemter, L., Jansen, H., Calafat, J., Oomen, L. C. J. M., Elferink, R. P. J. O., Borst, P., & Schinkel, A. H. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118535 · Cited by 261 · see citing works

In vitro P-glycoprotein affinity for atypical and conventional antipsychotics

Boulton, D. W., DeVane, C. L., Liston, H. L., et al. (2002) · Life Sciences · doi:10.1016/s0024-3205(02)01680-6 · Cited by 260 · see citing works

The influence of MDR1 polymorphisms on P-glycoprotein expression and function in humans

Fromm, M. F. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00064-9 · Cited by 249 · see citing works

ATPase activity of purified and reconstituted P-glycoprotein from Chinese hamster ovary cells.

Shapiro, A. B., & Ling, V. W. T. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)41923-5 · Cited by 232 · see citing works

Neuroprotective Antioxidants from Marijuana a

Hampson, A. J., GRIMALDI, M., Miljkovic-Lolic, M., Wink, D. A., Rosenthal, R., & Axelrod, J. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06193.x · Cited by 203 · see citing works

Multidrug resistance and the role of P-glycoprotein knockout mice

Schinkel, A. H., Mol, C. A. A. M., Wagenaar, E., van Deemter, L., Smit, J., & Borst, P. (1995) · European Journal of Cancer · doi:10.1016/0959-8049(95)00130-b · Cited by 199 · see citing works

Daunorubicin-resistant Chinese hamster ovary cells expressing multidrug resistance and a cell-surface P-glycoprotein.

Kartner, N., Shales, M., Riordan, J. R., & Ling, V. W. T. (1983) · PubMed · Cited by 199 · see citing works

Functional expression and localization of P‐glycoprotein at the blood brain barrier

Bendayan, R., Lee, G. S., & Bendayan, M. (2002) · Microscopy Research and Technique · doi:10.1002/jemt.10090 · Cited by 186 · see citing works

Randomized, Double-Blind, Placebo-Controlled Study About the Effects of Cannabidiol (CBD) on the Pharmacokinetics of Δ9-Tetrahydrocannabinol (THC) After Oral Application of THC Verses Standardized Cannabis Extract

Nadulski, T., Pragst, F., Weinberg, G., Roser, P., Schnelle, M., Fronk, E., & Stadelmann, A. M. (2005) · Therapeutic Drug Monitoring · doi:10.1097/01.ftd.0000177223.19294.5c · Cited by 186 · see citing works

Cannabidiol inhibits human glioma cell migration through a cannabinoid receptor‐independent mechanism

Vaccani, A., Massi, P., Colombo, A., Rubino, T., & Parolaro, D. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706134 · Cited by 154 · see citing works

Characterization of an "in vitro" blood-brain barrier: effects of molecular size and lipophilicity on cerebrovascular endothelial transport rates of drugs.

Bree, J. B., Boer, A. G. D., Danhof, M., Ginsel, L. A., & Breimer, D. D. (1988) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)13283-7 · Cited by 136 · see citing works

Increased oral bioavailability of paclitaxel by GF120918 in mice through selective modulation of P-glycoprotein.

Bardelmeijer, H. A., Beijnen, J. H., Brouwer, K. R., Rosing, H., Nooijen, W. J., Schellens, J. H. M., & van Tellingen, O. (2000) · PubMed · Cited by 121 · see citing works

Specificity of doxorubicin versus rhodamine-123 in assessing P-glycoprotein functionality in the LLC-PK1, LLC-PK1:MDR1 and Caco-2 cell lines

van der Sandt, I. C. J., Blom-Roosemalen, M. C. M., de Boer, A. G., et al. (2000) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(00)00097-x · Cited by 111 · see citing works

Structure and Function of P-Glycoprotein in Normal Liver and Small Intestine

Gatmaitan, Z., & Arias, I. M. (1993) · Advances in pharmacology · doi:10.1016/s1054-3589(08)60934-5 · Cited by 106 · see citing works

A phase I trial of doxorubicin, paclitaxel, and valspodar (PSC 833), a modulator of multidrug resistance.

Advani, R. H., Fisher, G. A., Lum, B. L., et al. (2001) · PubMed · Cited by 81 · see citing works

Olanzapine Penetration into Brain is Greater in Transgenic Abcb1a P-glycoprotein-Deficient Mice than FVB1 (Wild-Type) Animals

Wang, J.-S., Taylor, R. M., Ruan, Y., et al. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300372 · Cited by 81 · see citing works

Cannabinoid-induced alterations in brain disposition of drugs of abuse 11Abbreviations: THC, tetrahydrocannabinol; CBD, cannabidiol; PCP, phencyclidine; MDMA, 3,4-methylenedioxyphenyl-methamphetamine HCl.

Reid, M. J. A., & Bornheim, L. M. (2001) · Biochemical Pharmacology · doi:10.1016/s0006-2952(01)00616-5 · Cited by 70 · see citing works

Effect of verapamil on pharmacokinetics and pharmacodynamics of risperidone: In vivo evidence of involvement of P-glycoprotein in risperidone disposition

Nakagami, T., Yasui‐Furukori, N., SAITO, M., TATEISHI, T., & KANEO, S. (2005) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2005.03.009 · Cited by 68 · see citing works

Phase I/II Trial of the Multidrug-Resistance Modulator Valspodar Combined With Cisplatin and Doxorubicin in Refractory Ovarian Cancer

Baekelandt, M. M. O., Lehne, G., Tropé, C. G., Szántó, I., Pfeiffer, P., Gustavssson, B., & Kristensen, G. B. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.12.2983 · Cited by 64 · see citing works

Identification of P-glycoprotein in renal brush border membranes

Lieberman, D. M., Reithmeier, R. A. F., Ling, V. W. T., et al. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)91988-8 · Cited by 51 · see citing works

P-Glycoprotein expression in human, mouse, hamster and rat hepatocytes in primary culture

Fardel, O., Morel, F., & Guillouzo, A. (1993) · Carcinogenesis · doi:10.1093/carcin/14.4.781 · Cited by 47 · see citing works

Rhodamine 123 accumulates extensively in the isolated perfused rat kidney and is secreted by the organic cation system

Masereeuw, R., Moons, M. M., & Rüssel, F. G. M. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(96)00957-0 · Cited by 41 · see citing works

Heterologous Expression of Various P-Glycoproteins in Polarized Epithelial Cells Induces Directional Transport of Small (Type 1) and Bulky (Type 2) Cationic Drugs

Smit, J. W., Weert, B., Schinkel, A. H., et al. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37590-1 · Cited by 40 · see citing works

Effect of E6, a novel calmodulin inhibitor, on activity of P-glycoprotein in purified primary cultured rat brain microvessel endothelial cells.

Zhu, H., & Liu, G. (2003) · PubMed · Cited by 11 · see citing works

Cannabinoids and Immune Function

Killestein, J., Uitdehaag, B. M. J., & Polman, C. H. (2003) · JAMA · doi:10.1001/jama.290.6.754-b · Cited by 3 · see citing works

The pharmacokinetics and the pharmacodynamics of cannabinoids

Lucas, C. J., Galettis, P., & Schneider, J. (2018) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.13710 · Cited by 724 · see citing works

Safety and side effects of cannabidiol, a Cannabis sativa constituent

Machado Bergamaschi, M., Helena Costa Queiroz, R., Waldo Zuardi, A., & Alexandre S. Crippa, J. (2011) · Current Drug Safety · doi:10.2174/157488611798280924 · Cited by 558 · see citing works

Cannabidiol—recent advances

Mechoulam, R., Peters, M., Murillo‐Rodriguez, E., & Hanuš, L. O. (2007) · Chemistry & Biodiversity · doi:10.1002/cbdv.200790147 · Cited by 515 · see citing works

The multidrug transporter ABCG2 (BCRP) is inhibited by plant‐derived cannabinoids

Holland, M. L., Lau, D. T. T., Allen, J. D., & Arnold, J. C. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707467 · Cited by 150 · see citing works

Antihyperalgesic effect of a <i>Cannabis sativa</i> extract in a rat model of neuropathic pain: mechanisms involved

Comelli, F., Giagnoni, G., Bettoni, I., Colleoni, M., & Costa, B. (2008) · Phytotherapy Research · doi:10.1002/ptr.2401 · Cited by 103 · see citing works

Clinical Practice Guidelines for Cannabis and Cannabinoid-Based Medicines in the Management of Chronic Pain and Co-Occurring Conditions

Bell, A. D., MacCallum, C., Margolese, S., Walsh, Z., Wright, P., Daeninck, P. J., Mandarino, E., Lacasse, G., Kaur Deol, J., de Freitas, L., et al. (2024) · Cannabis &amp; Cannabinoid Research · doi:10.1089/can.2021.0156 · Cited by 78 · see citing works

Marijuana use in transplantation: a call for clarity

Levi, M. E., Montague, B. T., Thurstone, C., Kumar, D., Huprikar, S. S., Kotton, C. N., & the Executive Committee of the Infectious Diseases Community of Practice of the American Society of Transplantation (2019) · Clinical Transplantation · doi:10.1111/ctr.13456 · Cited by 38 · see citing works

Interactions ofΔ 11-tetrahydrocannabinol with cannabinol and cannabidiol following oral administration in man. Assay of cannabinol and cannabidiol by mass fragmentographywith cannabinol and cannabidiol following oral administration in man. Assay of cannabinol and cannabidiol by mass fragmentography

Agurell, S., Carlsson, S., Lindgren, J. E., Ohlsson, A., Gillespie, H., & Hollister, L. (1981) · Experientia · doi:10.1007/bf02085029 · Cited by 129 · see citing works

Cannabinoids and metabolites in expectorated oral fluid following controlled smoked cannabis

Milman, G., Schwope, D. M., Gorelick, D. A., & Huestis, M. A. (2012) · Clinica Chimica Acta · doi:10.1016/j.cca.2012.01.011 · Cited by 61 · see citing works

Étude des cinétiques sanguines et cérébrales du Δ9-tétrahydrocannabinol, de ses métabolites, du cannabidiol et du cannabinol chez la souris. Application à l'homme Kinetic study of Δ9-tetrahydrocannabinol, its metabolites, cannabidiol and cannabinol in the blood and brain of mice. Application to humans

Duverneuil-Mayer, C., Charlier, P., Abé, E., et al. (2011) · Cited by 1 · see citing works

Interactions in man of delta‐9‐tetrahydrocannabinol; II. Cannabinol and cannabidiol

Hollister, L. E., & Gillespie, H. K. (1975) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt197518180 · Cited by 84 · see citing works

Cannabidiol attenuates Δ9-tetrahydrocannabinol-like discriminative stimulus effects of cannabinol

Hiltunen, A. J., & Järbe, T. U. C. (1986) · European Journal of Pharmacology · doi:10.1016/0014-2999(86)90042-7 · Cited by 13 · see citing works